Similar sensitivity was observed when recombinant free and ARS-1620-bound KRASG12C protein was spiked into lysate from a resected human tumor sample that did not harbor a KRAS mutation (Supplementary Fig. S1). The gene discussed is KRAS; the disease is neoplasm.